Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-14

Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluated the efficacy and safety of DR-103 for pregnancy prevention and has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DR-103

Snippet

Sponsor: Teva Women's Health | Conditions: Pregnancy Prevention | Phase 3 | Status: COMPLETED | Results posted: 2013-06-14